These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7833283)

  • 1. Post-transplant lymphoproliferative disorders with genetic abnormalities commonly found in malignant tumours.
    Delecluse HJ; Rouault JP; Ffrench M; Dureau G; Magaud JP; Berger F
    Br J Haematol; 1995 Jan; 89(1):90-7. PubMed ID: 7833283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus infection and malignant lymphomas in liver transplant recipients.
    Niedobitek G; Mutimer DJ; Williams A; Whitehead L; Wilson P; Rooney N; Young LS; Hübscher SG
    Int J Cancer; 1997 Nov; 73(4):514-20. PubMed ID: 9389565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients.
    Dockrell DH; Strickler JG; Paya CV
    Clin Infect Dis; 1998 Jan; 26(1):180-2. PubMed ID: 9455529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl6/Laz3 rearrangements in post-transplant lymphoproliferative disorders.
    Delecluse HJ; Rouault JP; Jeammot B; Kremmer E; Bastard C; Berger F
    Br J Haematol; 1995 Sep; 91(1):101-3. PubMed ID: 7577614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.
    Knowles DM; Cesarman E; Chadburn A; Frizzera G; Chen J; Rose EA; Michler RE
    Blood; 1995 Jan; 85(2):552-65. PubMed ID: 7812011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
    Scheinfeld AG; Nador RG; Cesarman E; Chadburn A; Knowles DM
    Am J Pathol; 1997 Sep; 151(3):805-12. PubMed ID: 9284829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T gamma/delta hepatosplenic lymphoma in a heart transplant patient after an Epstein-Barr virus positive lymphoproliferative disorder: a case report.
    Kraus MD; Crawford DF; Kaleem Z; Shenoy S; MacArthur CA; Longtine JA
    Cancer; 1998 Mar; 82(5):983-92. PubMed ID: 9486591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.
    Capello D; Berra E; Cerri M; Gaidano G
    Minerva Med; 2004 Feb; 95(1):53-64. PubMed ID: 15041926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.
    Brink AA; Dukers DF; van den Brule AJ; Oudejans JJ; Middeldorp JM; Meijer CJ; Jiwa M
    J Clin Pathol; 1997 Nov; 50(11):911-8. PubMed ID: 9462239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders.
    Delecluse HJ; Kremmer E; Rouault JP; Cour C; Bornkamm G; Berger F
    Am J Pathol; 1995 May; 146(5):1113-20. PubMed ID: 7747805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease.
    Perera SM; Thomas JA; Burke M; Crawford DH
    J Pathol; 1998 Feb; 184(2):177-84. PubMed ID: 9602709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
    Fellner MD; Durand KA; Solernou V; Bosaleh A; Balbarrey Z; García de Dávila MT; Rodríguez M; Irazu L; Alonio LV; Picconi MA
    Rev Argent Microbiol; 2016; 48(2):110-8. PubMed ID: 27157146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Post-transplantation lymphomas and Epstein-Barr virus].
    Caillard S; Heibel F; Benaicha M; Moulin B
    Nephrologie; 1998; 19(8):481-8. PubMed ID: 9894641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders.
    Chetty R; Biddolph S; Kaklamanis L; Cary N; Stewart S; Giatromanolaki A; Gatter K
    J Pathol; 1996 Nov; 180(3):254-8. PubMed ID: 8958801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.
    Leblond V; Sutton L; Dorent R; Davi F; Bitker MO; Gabarre J; Charlotte F; Ghoussoub JJ; Fourcade C; Fischer A
    J Clin Oncol; 1995 Apr; 13(4):961-8. PubMed ID: 7707124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplant lymphoproliferative disorders: implications for acquired immunodeficiency syndrome-associated malignancies.
    Swinnen LJ
    J Natl Cancer Inst Monogr; 2001; (28):38-43. PubMed ID: 11158205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.
    Zimmermann H; Oschlies I; Fink S; Pott C; Neumayer HH; Lehmkuhl H; Hauser IA; Dreyling M; Kneba M; Gärtner B; Anagnostopoulos I; Riess H; Klapper W; Trappe RU
    Transplantation; 2012 Mar; 93(5):543-50. PubMed ID: 22234349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-associated lymphoproliferative disorders in oral cavity after heart transplantation: report of a case.
    Chang H; Wu JD; Cheng KK; Tseng HH
    J Formos Med Assoc; 1994 Apr; 93(4):332-6. PubMed ID: 7914777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
    Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
    Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.
    Cesarman E; Chadburn A; Liu YF; Migliazza A; Dalla-Favera R; Knowles DM
    Blood; 1998 Oct; 92(7):2294-302. PubMed ID: 9746767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.